Investor profile
Omega Funds
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Omega Funds is a leading international healthcare venture capital firm focused on delivering impactful medicines to patients. The firm creates and invests in life sciences companies that target the world's most urgent medical needs — including oncology, immunology, rare diseases, precision medicine, and medical devices — across the US and Europe. Omega's investment process starts by focusing on the endgame first: how to deliver impactful medicines to patients. The firm supports management teams through company creation, early venture rounds, and later-stage financings, investing in 'transformative, not incremental, innovation' across the full arc of innovation from formation through clinical milestones and commercial adoption.
Notable quotes
“As with prior funds, Fund VIII will support management teams in the U.S. and Europe through company creation, early venture rounds, and later-stage financings. We believe our broad investment strategy is well-positioned for navigating this period of macro and policy uncertainty. We look forward to contributing our capital, expertise, and network connectivity in partnering with entrepreneurs, founders, co-investors, and the broader community to transform the standards of care for severe diseases.”
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Windward Bio | Series B | $200m | 2026-05-04 |
| Third Arc Bio | Series A Extension | $52m | 2026-02-04 |
| Caldera Therapeutics | Series A Extension | $38m | 2026-01-14 |
| Aviceda Therapeutics | Series C | $208m | 2025-01-01 |
| Callio Therapeutics | Series A | $187m | 2025-01-01 |
| EDITAS Medicine | Series A | — | — |
| Juno Therapeutics | Venture | — | — |
| Prevail Therapeutics | Venture | — | — |
| Morphic Therapeutic | Venture | — | — |
| Scorpion Therapeutics | Venture | — | — |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Atlas Venture | 8 |
| OrbiMed | 7 |
| Sofinnova Partners | 6 |
| New Enterprise Associates (NEA) | 5 |
| Abingworth | 5 |
| RA Capital Management | 4 |
Fit check
Is Omega Funds a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit